These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32997214)

  • 1. Hemodynamic effects of ivabradine use in combination with intravenous inotropic therapy in advanced heart failure.
    Elzeneini M; Aranda JM; Al-Ani M; Ahmed MM; Parker AM; Vilaro JR
    Heart Fail Rev; 2021 Mar; 26(2):355-361. PubMed ID: 32997214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of ivabradine in cardiogenic shock.
    Chiu MH; Howlett JG; Sharma NC
    ESC Heart Fail; 2019 Oct; 6(5):1088-1091. PubMed ID: 31332966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversing dobutamine-induced tachycardia using ivabradine increases stroke volume with neutral effect on cardiac energetics in left ventricular post-ischaemia dysfunction.
    Bakkehaug JP; Naesheim T; Torgersen Engstad E; Kildal AB; Myrmel T; How OJ
    Acta Physiol (Oxf); 2016 Oct; 218(2):78-88. PubMed ID: 27145482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate control and haemodynamic improvement with ivabradine in cardiogenic shock patient on mechanical circulatory support.
    Colombo CNJ; Dammassa V; Klersy C; Camporotondo R; Pellegrini C; Mojoli F; Tavazzi G
    Eur Heart J Acute Cardiovasc Care; 2022 Dec; 11(12):916-921. PubMed ID: 36222185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial.
    Nguyen LS; Squara P; Amour J; Carbognani D; Bouabdallah K; Thierry S; Apert-Verneuil C; Moyne A; Cholley B
    Crit Care; 2018 Aug; 22(1):193. PubMed ID: 30115103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivabradine in acute heart failure: Effects on heart rate and hemodynamic parameters in a randomized and controlled swine trial.
    Pascual Izco M; Ramírez-Carracedo R; Hernández Navarro I; Osorio Ruiz Á; Castejón Navarro B; Cuadrado Berrocal I; Largo Aramburu C; Alonso Salinas GL; Díez J; Saura Redondo M; Zamorano JL; Zaragoza C; Sanmartín M
    Cardiol J; 2020; 27(1):62-71. PubMed ID: 30155868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of Ivabradine in addition to dobutamine in patients with severe systolic dysfunction.
    Gallet R; Ternacle J; Damy T; Guendouz S; Bremont C; Seemann A; Gueret P; Dubois-Rande JL; Lim P
    Int J Cardiol; 2014 Sep; 176(2):450-5. PubMed ID: 25129291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure.
    Pereira-Barretto AC
    Adv Ther; 2015 Oct; 32(10):906-19. PubMed ID: 26521191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB; Moen EK
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inotropic therapy for heart failure: an evidence-based approach.
    Felker GM; O'Connor CM
    Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation of Intravenous Catecholamine by Oral Ivabradine in a Patient with Decompensated Heart Failure with Low Cardiac Output Syndrome.
    Shibata R; Takahashi J; Sato H; Bekki M; Shibao K; Sato H; Nohara S; Honda A; Itaya N; Chibana H; Fukumoto Y
    Kurume Med J; 2023 Jul; 68(2):133-140. PubMed ID: 37062727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inotropes.
    Francis GS; Bartos JA; Adatya S
    J Am Coll Cardiol; 2014 May; 63(20):2069-2078. PubMed ID: 24530672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased sarcoplasmic/endoplasmic reticulum calcium ATPase 2a activity underlies the mechanism of the positive inotropic effect of ivabradine.
    Xie M; Huang HL; Zhang WH; Gao L; Wang YW; Zhu XJ; Li W; Chen KS; Boutjdir M; Chen L
    Exp Physiol; 2020 Mar; 105(3):477-488. PubMed ID: 31912915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the contemporary use of inotropes in patients with heart failure.
    Neicheril R; Snipelisky D
    Curr Opin Cardiol; 2024 Mar; 39(2):104-109. PubMed ID: 38170194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and management of acute heart failure and cardiogenic shock: role of inotropic therapy.
    McGhie AI; Golstein RA
    Chest; 1992 Nov; 102(5 Suppl 2):626S-632S. PubMed ID: 1424938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM
    Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Inotropic Agents in Treatment of Systolic Heart Failure.
    Tariq S; Aronow WS
    Int J Mol Sci; 2015 Dec; 16(12):29060-8. PubMed ID: 26690127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
    J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart Failure.
    Imamura T; Kinugawa K
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.